학술논문

Patients with NSCLCs harboring internal inversions or deletion rearrangements of the ALK gene have durable responses to ALK kinase inhibitors
Document Type
Article
Source
In: Lung Cancer: Targets and Therapy. (Lung Cancer: Targets and Therapy, 2020, 11:33-39)
Subject
Language
English
ISSN
11792728